{
    "Trade/Device Name(s)": [
        "25-Hydroxy Vitamin D(s) EIA"
    ],
    "Submitter Information": "Immunodiagnostic Systems Limited",
    "510(k) Number": "K142351",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021163"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "August 14, 2015",
    "Summary Letter Received Date": "August 19, 2015",
    "Submission Date": "August 18, 2015",
    "Regulation Number(s)": [
        "21CFR862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "25-hydroxyvitamin D",
        "other hydroxylated vitamin D metabolites",
        "25(OH)D3",
        "25(OH)D2",
        "24,25-(OH)2D3",
        "3-epi-25(OH)D3",
        "3-epi-25(OH)D2",
        "1,25-(OH)2D3",
        "1,25-(OH)2D2",
        "Vitamin D3 (Cholecalciferol)",
        "Vitamin D2 (Ergocalciferol)",
        "Paricalcitol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Standard sampling tubes",
        "Serum separator tubes (SST)",
        "EDTA tubes",
        "Lithium heparin tubes",
        "Sodium heparin tubes",
        "Citrate tubes",
        "Tubes containing serum separating gel"
    ],
    "Instrument(s)/Platform(s)": [
        "Microtitre plate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Immunodiagnostic Systems Limited 25-Hydroxy Vitamin D(s) EIA for quantitation of vitamin D and hydroxylated metabolites in serum/plasma",
    "Indications for Use Summary": "Intended for the quantitative determination of 25-hydroxyvitamin D and other hydroxylated metabolites in adult human serum or plasma to assist clinicians in assessing vitamin D sufficiency, for in vitro diagnostic use",
    "fda_folder": "Clinical Chemistry"
}